LOW KINETIC HYDROGEN ISOTOPE EFFECTS IN THE DEHYDROGENATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIMETHYL ESTER (NIFEDIPINE) BY CYTOCHROME-P-450 ENZYMES ARE CONSISTENT WITH AN ELECTRON PROTON ELECTRON-TRANSFER MECHANISM

被引:27
|
作者
GUENGERICH, FP [1 ]
机构
[1] VANDERBILT UNIV,CTR MOLEC TOXICOL,NASHVILLE,TN 37232
关键词
D O I
10.1021/tx00013a004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P-450 enzymes have been postulated to oxidize amines through a variety of mechanisms. One of the means of distinguishing among potential pathways involves the use of kinetic hydrogen isotope effects: low isotope effects are characteristic of aminium radical mechanisms while high values are consistent with hydrogen atom abstraction, a process documented in alkane hydroxylation. Nifedipine [1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5- pyridinedicarboxylic acid dimethyl ester] was prepared with isotopic substitution at the 4-position and utilized in determinations of the deuterium and tritium kinetic isotope effects. The noncompetitive intermolecular deuterium [DV,D(V/K)] and competitive intermolecular tritium [T(V/K)] isotope effects observed in the oxidation of nifedipine with liver microsomes prepared from untreated male rats were <2. Similar low deuterium and tritium isotope effects (<2) were also found with six other types of rat liver microsomal preparations and with three different human liver microsomal preparations, even though the rates of oxidation (expressed per nanomole of total cytochrome P-450) varied by an order of magnitude and other investigations indicate that several different cytochrome P-450 enzymes can catalyze the reaction. Similar low deuterium and tritium isotope effects were measured with a purified rat liver cytochrome P-450 preparation and horseradish peroxidase. These results are interpreted in terms of an electron/proton/electron transfer mechanism previously postulated for the oxidation of other dihydropyridines by cytochrome P-450 enzymes and model one-electron acceptors and argue against a mechanism involving hydrogen atom abstraction from nifedipine. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 19 条
  • [1] BIOTRANSFORMATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-TRIFLUOROMETHYLPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
    PARKER, SE
    WEINSTOCK, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (01) : 34 - 37
  • [2] METABOLISM OF ANTIHYPERTENSIVE AGENT 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-TRIFLUOROMETHYLPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
    WALKENSTEIN, SS
    INTOCCIA, AP
    FLANAGAN, TL
    HWANG, B
    FLINT, D
    WEINSTOCK, J
    VILLANI, AJ
    BLACKBURN, D
    GREEN, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (04) : 580 - 584
  • [4] SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF STEREOISOMERS OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID METHYL 1-(PHENYLMETHYL)-3-PIPERIDINYL ESTER
    MUTO, K
    KURODA, T
    KAWATO, H
    KARASAWA, A
    KUBO, K
    NAKAMIZO, N
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (11A): : 1662 - 1665
  • [5] Synthesis and X-ray crystal structure of 1,4-dihydro-2,6-dimethyl-4-(2'-isopropylphenyl)-3,5-pyridine-dicarboxylic acid dimethyl ester: A nifedipine analogue
    Palmer, RB
    Andersen, NH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) : 2173 - 2176
  • [6] EFFECTS OF THE NEW DIHYDROPYRIDINE DERIVATIVE 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID METHYL 6-(5-PHENYL-3-PYRAZOLYLOXY)HEXYL ESTER ON THE CARDIOHEMODYNAMICS AND THE ENERGY-METABOLISM OF ISCHEMIC MYOCARDIUM
    IMAI, H
    MATSUI, K
    OCHI, S
    NAKAZAWA, M
    NAKAGAWA, Y
    IMAI, S
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-2 (12): : 1348 - 1352
  • [7] Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), on rat ischemic brain injury
    Miyazaki, H
    Tanaka, S
    Fujii, Y
    Shimizu, K
    Nagashima, K
    Kamibayashi, M
    Uehara, T
    Okuma, Y
    Nomura, Y
    LIFE SCIENCES, 1999, 64 (10) : 869 - 878
  • [8] EMPLOYING IONIZATION BEHAVIORS TO RESOLVE A TRACE-LEVEL IMPURITY - DETERMINATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DI-2-[METHYL-(PHENYLMETHYL)AMINO]ETHYL ESTER IN NICARDIPINE DRUG SUBSTANCE
    MAURIN, MB
    VICKERY, RD
    MA, P
    MANALO, J
    HUSSAIN, MA
    PHARMACEUTICAL RESEARCH, 1992, 9 (11) : 1518 - 1520
  • [9] PHARMACOLOGY OF A NEW CALCIUM ANTAGONISTIC COMPOUND, ISOBUTYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE (NISOLDIPINE, BAY-K-5552)
    KAZDA, S
    GARTHOFF, B
    MEYER, H
    SCHLOSSMANN, K
    STOEPEL, K
    TOWART, R
    VATER, W
    WEHINGER, E
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1980, 30-2 (12): : 2144 - 2162
  • [10] CARDIOVASCULAR EFFECTS OF THE NEW GENERATION CALCIUM-ANTAGONIST 3-PYRIDINE CARBOXYLIC-ACID 5-[(CYCLOPROPYLAMINO)CARBONYL]-1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)OCTYL ESTER
    HOJO, M
    TERAMOTO, N
    HATA, H
    KATAYAMA, O
    TATSUMI, H
    SHIBATA, S
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1992, 42-1 (05): : 621 - 628